HRP20080494T3 - Derivati 1-fenilalkankarboksilnih kiselina za tretman neurodegenerativnih bolesti - Google Patents
Derivati 1-fenilalkankarboksilnih kiselina za tretman neurodegenerativnih bolestiInfo
- Publication number
- HRP20080494T3 HRP20080494T3 HR20080494T HRP20080494T HRP20080494T3 HR P20080494 T3 HRP20080494 T3 HR P20080494T3 HR 20080494 T HR20080494 T HR 20080494T HR P20080494 T HRP20080494 T HR P20080494T HR P20080494 T3 HRP20080494 T3 HR P20080494T3
- Authority
- HR
- Croatia
- Prior art keywords
- branched
- substituted
- linear
- alkyl
- groups
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 abstract 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 abstract 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 abstract 2
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 abstract 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 abstract 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 abstract 1
- ABADUMLIAZCWJD-UHFFFAOYSA-N 1,3-dioxole Chemical compound C1OC=CO1 ABADUMLIAZCWJD-UHFFFAOYSA-N 0.000 abstract 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 abstract 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 abstract 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 101100134922 Gallus gallus COR5 gene Proteins 0.000 abstract 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 abstract 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 abstract 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 abstract 1
- -1 methylenedioxy, ethylenedioxy Chemical group 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Spojevi opće formule (I): naznačeni time daB je Hili bočni lanac alfa-aminokiseline, R i R1, su isti te predstavljaju linearni ili razgranati C1-C4 alkil, ili tvore prsten od 3 do 6 atoma ugljika nakoji su spojeni, Ar je fenil supstituiran s jednim ili više skupina R3 pri čemu R3 predstavlja: - halogen kako je prethodno definiran, CF3, C3-C8 cikloalkil koji može biti supstituiran s jednim ili više C1-C4 alkil i/ili okso skupinama, CH=CH2, NO2lCH2OH, CN, metilendioksi, etilendioksi, - fenil koji može biti supstituiran s jednom ili više sljedećih skupina: halogen kako je prethodno definiran,CF3, OCF3, OH, linearni ili razgranati C1-C4 alkil, zasićeni heterociklil s najmanje 4 atoma ugljika s najmanje 1 heteroatomom, C3-C8 cikloalkil kojimože biti supstituiran s jednom ili više linearnih ili razgranatih C1-C4 alkilnih skupina, CF3 i/ili OH, - OR4 ili NHCOR4 gdje R4 jest CF3, linearni ili razgranati C2-C6 alkenil ili alkilnil, benzil,fenil koji može biti supstituiran s jednom ili više sljedećih skupina: halogen kako je prethodno definiran, CF3, OCF3, OH, linearni ili razgranati C1-C4 alkil, zasićeni heterociklil s najmanje 4 atoma ugljika i najmanje 1 heteroatomom, C3-C8 cikloalkil koji može biti supstituiran s jednom ili više linearih ili razgranatih C1-C4 alkilnih skupina, CF3 i/ili OH, - SR5, SO2R5 ili COR5, gdje R5jest linearni ili razgranati C1-C6 alkil, ili je Ar heterociklil odabran iz sljedeće skupine: pirol, pirazol, furan, thiofen, indol, izoindol, benzofuran, benzotiofen, imidazol, oksazol, izoksazol, tiazol, benzoimidazol, benzoksazol, benzotiazol, pirimidin,pirazin, kinolin, izokinolin, kinazolin, kinoksalin, dibenzofuran, dibenzo-iofen, tiantren, karbazol, piridazin, cinolin, ftalazin, 1,5-nafthiridin, 1,3-dioksol, 1,3-benzodioksol, a rečeni heterociklički prsten može biti supstituiran s jednom ili više R3 kako je gore definiran. Patent sadrži još 10patentnih zahtjeva.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04425604 | 2004-08-03 | ||
| PCT/IB2005/002189 WO2006016219A2 (en) | 2004-08-03 | 2005-07-26 | Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20080494T3 true HRP20080494T3 (hr) | 2008-11-30 |
Family
ID=35462580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080494T HRP20080494T3 (hr) | 2004-08-03 | 2008-10-01 | Derivati 1-fenilalkankarboksilnih kiselina za tretman neurodegenerativnih bolesti |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7531692B2 (hr) |
| EP (1) | EP1778623B1 (hr) |
| JP (1) | JP4866851B2 (hr) |
| KR (1) | KR101156393B1 (hr) |
| CN (1) | CN1984878B (hr) |
| AT (1) | ATE399758T1 (hr) |
| AU (1) | AU2005270949B2 (hr) |
| BR (1) | BRPI0513647A (hr) |
| CA (1) | CA2576009C (hr) |
| CY (1) | CY1110401T1 (hr) |
| DE (1) | DE602005007912D1 (hr) |
| DK (1) | DK1778623T3 (hr) |
| ES (1) | ES2309778T3 (hr) |
| HK (1) | HK1104280A1 (hr) |
| HR (1) | HRP20080494T3 (hr) |
| NO (1) | NO339921B1 (hr) |
| PL (1) | PL1778623T3 (hr) |
| PT (1) | PT1778623E (hr) |
| RS (1) | RS50601B (hr) |
| SI (1) | SI1778623T1 (hr) |
| WO (1) | WO2006016219A2 (hr) |
| ZA (1) | ZA200700945B (hr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101152448B1 (ko) | 2003-02-21 | 2012-07-02 | 키에시 파르마슈티시 엣스. 피. 에이. | 신경 퇴행성 질환의 치료를 위한 1-페닐알캔카복실산 추출물의 제조방법 |
| KR20130079353A (ko) | 2010-04-21 | 2013-07-10 | 키에시 파르마슈티시 엣스. 피. 에이. | 트랜스티레틴 아밀로이드증 치료용 1-(2-플루오로비페닐-4-일)-알킬 카복실산 유도체 |
| RU2012151850A (ru) | 2010-06-04 | 2014-07-20 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Производные 1-(2-фторбифенил-4-ил)циклопропанкарбоновой кислоты для терапии прионных болезней |
| US9592210B2 (en) | 2011-12-22 | 2017-03-14 | Chiesi Farmaceutici S.P.A. | 1-phenylalkanecarboxylic acid derivatives for the treatment of cognitive impairment |
| KR20140144178A (ko) | 2012-04-04 | 2014-12-18 | 키에시 파르마슈티시 엣스. 피. 에이. | 신경퇴행성 질환의 치료를 위한 1-(2-할로-비페닐-4-일)알칸카복실산의 유도체 |
| US20150335596A1 (en) | 2014-05-26 | 2015-11-26 | Chiesi Farmaceutici S.P.A. | 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the treatment of down's syndrome |
| CN111344287B (zh) | 2017-11-14 | 2023-12-19 | 默沙东有限责任公司 | 作为吲哚胺2，3-双加氧酶(ido)抑制剂的新型取代的联芳基化合物 |
| US11498904B2 (en) | 2017-11-14 | 2022-11-15 | Merck Sharp & Dohme Llc | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283489B1 (it) | 1996-07-23 | 1998-04-21 | Chiesi Farma Spa | Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico |
| US6211235B1 (en) | 1996-11-22 | 2001-04-03 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| US6191166B1 (en) | 1997-11-21 | 2001-02-20 | Elan Pharmaceuticals, Inc. | Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| US6117901A (en) | 1996-11-22 | 2000-09-12 | Athena Neurosciences, Inc. | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use |
| CA2279977A1 (en) * | 1997-02-04 | 1998-08-06 | John S. Kiely | 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries |
| US5994379A (en) | 1998-02-13 | 1999-11-30 | Merck Frosst Canada, Inc. | Bisaryl COX-2 inhibiting compounds, compositions and methods of use |
| FR2842523A1 (fr) | 2002-07-17 | 2004-01-23 | Sanofi Synthelabo | Derives d'acylaminothiazole, leur preparation et leur application en therapeutique |
| KR101152448B1 (ko) | 2003-02-21 | 2012-07-02 | 키에시 파르마슈티시 엣스. 피. 에이. | 신경 퇴행성 질환의 치료를 위한 1-페닐알캔카복실산 추출물의 제조방법 |
-
2005
- 2005-07-26 ZA ZA200700945A patent/ZA200700945B/xx unknown
- 2005-07-26 KR KR1020067027604A patent/KR101156393B1/ko not_active IP Right Cessation
- 2005-07-26 AU AU2005270949A patent/AU2005270949B2/en not_active Ceased
- 2005-07-26 WO PCT/IB2005/002189 patent/WO2006016219A2/en active Application Filing
- 2005-07-26 CN CN200580023905XA patent/CN1984878B/zh not_active Expired - Fee Related
- 2005-07-26 EP EP05767873A patent/EP1778623B1/en active Active
- 2005-07-26 RS RSP-2008/0392A patent/RS50601B/sr unknown
- 2005-07-26 CA CA2576009A patent/CA2576009C/en not_active Expired - Fee Related
- 2005-07-26 US US11/572,974 patent/US7531692B2/en not_active Expired - Fee Related
- 2005-07-26 SI SI200530328T patent/SI1778623T1/sl unknown
- 2005-07-26 BR BRPI0513647-4A patent/BRPI0513647A/pt not_active IP Right Cessation
- 2005-07-26 AT AT05767873T patent/ATE399758T1/de active
- 2005-07-26 ES ES05767873T patent/ES2309778T3/es active Active
- 2005-07-26 PL PL05767873T patent/PL1778623T3/pl unknown
- 2005-07-26 PT PT05767873T patent/PT1778623E/pt unknown
- 2005-07-26 JP JP2007524411A patent/JP4866851B2/ja not_active Expired - Fee Related
- 2005-07-26 DE DE602005007912T patent/DE602005007912D1/de active Active
- 2005-07-26 DK DK05767873T patent/DK1778623T3/da active
-
2007
- 2007-01-31 NO NO20070665A patent/NO339921B1/no not_active IP Right Cessation
- 2007-08-28 HK HK07109391.9A patent/HK1104280A1/xx not_active IP Right Cessation
-
2008
- 2008-09-04 CY CY20081100961T patent/CY1110401T1/el unknown
- 2008-10-01 HR HR20080494T patent/HRP20080494T3/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005007912D1 (de) | 2008-08-14 |
| AU2005270949A1 (en) | 2006-02-16 |
| CN1984878B (zh) | 2011-06-08 |
| KR101156393B1 (ko) | 2012-06-13 |
| CY1110401T1 (el) | 2015-04-29 |
| US20080096968A1 (en) | 2008-04-24 |
| ATE399758T1 (de) | 2008-07-15 |
| WO2006016219A2 (en) | 2006-02-16 |
| AU2005270949B2 (en) | 2011-02-03 |
| KR20070038982A (ko) | 2007-04-11 |
| EP1778623B1 (en) | 2008-07-02 |
| SI1778623T1 (sl) | 2008-10-31 |
| BRPI0513647A (pt) | 2008-05-13 |
| CN1984878A (zh) | 2007-06-20 |
| CA2576009A1 (en) | 2006-02-16 |
| CA2576009C (en) | 2013-02-26 |
| WO2006016219A3 (en) | 2006-04-27 |
| JP2008509124A (ja) | 2008-03-27 |
| JP4866851B2 (ja) | 2012-02-01 |
| HK1104280A1 (en) | 2008-01-11 |
| ES2309778T3 (es) | 2008-12-16 |
| RS50601B (sr) | 2010-05-07 |
| NO339921B1 (no) | 2017-02-13 |
| US7531692B2 (en) | 2009-05-12 |
| ZA200700945B (en) | 2008-09-25 |
| NO20070665L (no) | 2007-05-02 |
| EP1778623A2 (en) | 2007-05-02 |
| PT1778623E (pt) | 2008-09-29 |
| DK1778623T3 (da) | 2008-10-20 |
| PL1778623T3 (pl) | 2008-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20080494T3 (hr) | Derivati 1-fenilalkankarboksilnih kiselina za tretman neurodegenerativnih bolesti | |
| AR064212A1 (es) | Uso de profarmacos de analogos de gaba para tratar enfermedades | |
| ATE388146T1 (de) | 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor | |
| MX2015015893A (es) | 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen. | |
| EA200300777A1 (ru) | N-фенпропилциклопентил-замещенные производные глутарамида в качестве nep ингибиторов для fsad | |
| AR060150A1 (es) | Heteropentaciclos activos como inhibidores de quinasas, y su uso para tratar trastornos de la proliferacion celular | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| RS52627B (en) | 4-SUBSTITUTED Phenoxyphenylsulfuric acid derivatives | |
| AR053120A1 (es) | Aminopiridinas como inhibidores de beta secretasa | |
| CA2514384A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| AR029301A1 (es) | Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos | |
| ES2313079T3 (es) | Benzimidazol, benzotiazol, benzoxazol y su utilizacion como moduladores de lta4h. | |
| AR058562A1 (es) | Derivados de pirimido [4,5 b] (1,4) oxazinas , procedimientos de obtencion y su uso como inhibidores de acetil coa y dgat 1 | |
| MX2011010647A (es) | Analogos de isoxasol-3 (2h)-ona como agentes terapeuticos. | |
| HRP20070577T4 (hr) | Derivati kinazolinona koji se mogu upotrijebiti kao antagonisti vaniloida | |
| EA200901160A1 (ru) | Производные 3-циано-4-(4-тетрагидропиранфенил)пиридин-2-она | |
| DE602005014786D1 (de) | Oxazolderivate als histamin-h3-rezeptor-wirkstoffe, deren herstellung und therapeutische verwendung | |
| EA201001414A1 (ru) | Производные азетидина и их применение | |
| AR062886A1 (es) | Compuestos de tiazol pirazolopirimidina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento | |
| ATE463483T1 (de) | 6-substituierte isochinolinderivate als rock-1- inhibitoren | |
| RS53903B1 (en) | ETHINYL DERIVATIVES AS POSITIVE MGLUR5 MODULATORS | |
| CO6260069A2 (es) | Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa | |
| PE20091436A1 (es) | Derivados de sulfonamidas sustituidas como moduladores b1r | |
| PE20120223A1 (es) | Compuestos heterociclicos como inhibidores del transportador de glicina-1 (glyt-1) | |
| RU2010107603A (ru) | Производные n-(2-тиазолил)амида для лечения ожирения, диабетов и сердечно-сосудистых заболеваний |